Related Experiment Video
Updated: May 10, 2026

A High-throughput Shigella-specific Bactericidal Assay
Published on: February 27, 2019
Bacteriophages for managing Shigella in various clinical and non-clinical settings
1Department of Food Science and Agricultural Chemistry; Faculty of Agricultural and Environmental Sciences; McGill University; Montreal, QC Canada.
Abstract:
The control of shigellosis in humans enjoys a prominent position in the history of bacteriophage therapy. d'Herelle first demonstrated the efficacy of phage therapy by curing 4 patients of shigellosis, and several subsequent studies confirmed the ability of phages to reduce Shigella based infection. Shigella spp continue to cause millions of illnesses and deaths each year and the use of phages to control the disease in humans and the spread of the bacteria within food and water could point the way forward to the effective management of an infectious disease with global influence.
Related Concept Videos
Lytic Cycle of Bacteriophages
Biological Methods for Microbial Control
DNA Bacteriophages
Bacterial Gastroenteritis
Lysogenic Cycle of Bacteriophages
Clinical Significance of Antibiotic Resistance

